YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

ReNu MoistureLoc


AddThis Social Bookmark Button

Leading the Fight for those Injured by ReNu with MoistureLoc

Parker & Waichman, LLP is leading the fight against Bausch & Lomb, Inc. on behalf of people injured after using ReNu with MoistureLoc contact lens solution. We filed the first case against Bausch & Lomb, Inc. on behalf of a Fusarium keratitis victim and have since filed numerous cases in federal and state courts. Parker & Waichman, LLP also filed a medical monitoring class action against Bausch & Lomb, Inc. seeking compensation for medical evaluations for all people who used ReNu with MoistureLoc. There are many law firms looking for people with ReNu injuries, but don't trust your case to any firm. Trust Parker & Waichman, LLP, the leaders in defective medical product litigation.

ReNu with MoistureLoc Linked to Fusarium Keratitis
On April 10, 2006, Bausch & Lomb announced suspension of shipments of its contact solution ReNu with MoistureLoc.  Reports of fungal keratitis infections in users of the solution are surfacing in contact lens wearers who use ReNu with MoistureLoc.

Increase in fungal infections found
Just before Bausch & Lomb announced it was suspending shipments, the FDA warned of increasing numbers of the fungal infections in those who wear contact lenses.  There were 109 cases of Fusarium keratitis under investigation by public health authorities.  CDC data of 30 cases of the infections revealed that 28 wore contact lenses and that most used the ReNu saline.

Fungal keratitis
Fungal keratitis is a serious eye infection that can develop through the whole depth of the cornea.  The infection can require prolonged drug therapy with antifungals such as natamycin, nystatin, and amphotericin B. Other antifungals that may be administered include various Azoles and Fluorinated pyrimidines.  If drugs do not work and the eye is damaged, surgery may be necessary to remove fungal ulcers/lesions.  Symptoms of fungal keratitis include eye pain, eye discomfort, decrease in vision and light hypersensitivity.

FDA Recall
On May 15, 2006, Bausch & Lomb recalled its contact solution ReNu with MoistureLoc. The FDA and CDC have been investigating an increase in cases of fungal keratitis, an eye infection that affects the cornea and can cause permanent blindness.

Legal help for Renu MoistureLoc users
If you or a loved one developed an infection as a result of Bausch & Lomb Renu MoistureLoc saline solution, contact Parker & Waichman, LLP for a free case evaluation. Call 1-800-LAW-INFO (1-800-529-4636) or fill out the short form to the right.
ReNu MoistureLocRSS Feed

Tainted ReNu, AMO Contact Lens Solutions Prompt FDA Panel to Call for Better Testing

Jun 11, 2008 | Parker Waichman Alonso LLP
In the past several years, contact lens solutions, including ReNu with MoistureLoc and Advanced Medical Optics Complete MoisturePlus, have been linked to potentially blinding eye infections.  Now, a group of Food & Drug Administration (FDA) advisors has recommended that contact lens solutions be subjected to more stringent testing to insure their safety.  The panel also recommended that stronger safety warnings be added to the labels of multi-purpose contact lens solutions so that...

Bausch & Lomb Renu with MoistureLoc Tests Faulty, New Study Says

Jan 28, 2008 | Parker Waichman Alonso LLP
Renu with MoistureLoc, the Bausch & Lomb contact lens solution that was responsible for a massive outbreak of Fusarium Keratitis in 2006, was never adequately tested to insure that it was resistant to microbial contamination.   According to a new study conducted by researchers at the Center for Medical Mycology at University Hospitals Case Medical Center in Cleveland, Ohio, the strain of Fusarium used by Bausch & Lomb to test Renu with MoistureLoc was rare and outdated, making...

Bausch & Lomb CEO Steps Down, 2 Years after Renu with MoistureLoc Recall

Jan 24, 2008 | Parker Waichman Alonso LLP
The Bausch & Lomb CEO who oversaw the Renu with MoistureLoc recall debacle has stepped down.  Last year, under Ronald Zarella, who served as Bausch & Lomb CEO since 2001, the company was sold to private equity firm Warburg Pincus of New York City. The sale ended Bausch & Lomb's almost 70-year run as a publicly traded company.According to the Rochester Democrat & Chronicle, Zarrella will be replaced by Gerald M. Ostrov, who most recently was group chairman of Johnson &...

Bausch & Lomb, Still Reeling from ReNu with MoistureLoc Recall, Announces UK Job Cuts

Jan 15, 2008 | Parker Waichman Alonso LLP
Bausch & Lomb, the maker of recalled ReNu with MoistureLoc Contact Lens Solution, announced that it would be eliminating 250 jobs at one of its plants in the United Kingdom.  The job cuts are just the latest bit of bad news for Bausch & Lomb, which has never fully recovered from the 2006 ReNu with MoistureLoc recall.In 2006, Bausch & Lomb’s ReNu with MoistureLoc Contact Lens Solution was linked to Fusarium Keratitis, a rare eye infection that has the potential to cause...

Bausch & Lomb Goes to Court to Force Insurers to Pay for Renu with MoistureLoc Lawsuits

Jan 7, 2008 | Parker Waichman Alonso LLP
Bausch & Lomb, maker of the recalled Renu with MoistureLoc contact lens solution, is trying to force several insurance companies to help it pay for more than 1,000 lawsuits filed against the company over the tainted product.  That insurance battle is just one example of how the Renu with MoistureLoc recall is still causing problems for the company. Nearly two years later, Bausch & Lomb is still facing serious legal and financial ramifications of the Renu with MoistureLoc...

More ReNu MoistureLoc News

ReNu Contact Solution
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News